retatrutide and blood pressure Does Lower Pressure? What Phase 2 Actually Showed Retatrutide: What It Is &

These results suggest Retatrutide could be explored as a novel anti-tumor treatment, especially for obesity-associated cancers, potentially through metabolic or immune pathways beyond its weight-loss effects

[cited 29 Aug 2025]

Because retatrutide is not yet approved, its complete risk profile including rare, serious, or long-term adverse effects remains under investigation

This is generally not recommended

The biomarker data might point to specific groups of people who might still benefit and provide more information or how these drugs impact the biology of Alzheimers

Hims & Hers Pulls Back GLP-1 Weight-Loss Pill Shortly afterward, Hims & Hers Health abruptly abandoned its plan to launch a compounded version oral weight-loss pill priced as low as $49/month, backing off within days amid regulatory pressure and industry backlash